NP
Nascent Pharma Holdings, Inc.
SEC filingOther · Hicksville, NY
Amount raised$75Ksold at filing
Total offering$3M$2.9M still open
Investors in the raise2count reported to the SEC
FiledApr 10, 2026first sale Mar 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Stanley TeepleExecutive Officer, Director
Frederick Alger BoyerDirector
Marco AlfonsiExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.